These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14156392)

  • 21. [Clinical experiences with a new antitubercular drug: 4,4'-diisoamyloxythiocarbanilide (isoxyl)].
    Durigato S
    G Ital Chemioter; 1965; 12(1):110-20. PubMed ID: 5894081
    [No Abstract]   [Full Text] [Related]  

  • 22. [NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    LESTON JM
    Torax; 1963; 12():138-42. PubMed ID: 14159777
    [No Abstract]   [Full Text] [Related]  

  • 23. [STUDY OF THE HEPATOGRAM, PROTEINOGRAM, BLOOD CALCIUM, TRANSAMINASE AND PROTHROMBIN TIME IN THE INITIAL TUBERCULOSIS INFECTION TREATED WITH D.A.T.C].
    PERONCINI J; COSTA A; EZZOAUI JL; GNECCO V; DELLEPIANNE AR; GOYA E; OVIEDO M
    Sem Med; 1964 Mar; 124():691-3. PubMed ID: 14167978
    [No Abstract]   [Full Text] [Related]  

  • 24. ["2ND LINE" DRUG THERAPY IN CHRONIC TUBERCULOSIS DUE TO GERM RESISTANCE. (NEW METHODS OF DRUG ADMINISTRATION; NEW DRUGS)].
    HAMMERLI A; KRAMER EE; GALLINDO IS
    Hospital (Rio J); 1964 Feb; 65():365-88. PubMed ID: 14136756
    [No Abstract]   [Full Text] [Related]  

  • 25. [CLINICAL EXPERIENCE WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE (ISOXYL) IN PULMONARY TUBERCULOSIS].
    HORNUNG S; OWSINSKI J
    Gruzlica (1926); 1963 Jul; 31():173-80. PubMed ID: 14072804
    [No Abstract]   [Full Text] [Related]  

  • 26. [MORPHAZINAMIDE IN ANTUBERCULAR THERAPY].
    FOUQUET J; TEYSSIER L
    G Ital Chemioter; 1963; 10():164-70. PubMed ID: 14079399
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 28. DETERMINATION OF THE SENSITIVITY OF MYCOBACTERIA TO ISOXYL IN VITRO.
    VIRTANEN S
    Ann Med Exp Biol Fenn; 1963; 41():430-5. PubMed ID: 14085830
    [No Abstract]   [Full Text] [Related]  

  • 29. CORTICOSTEROIDS AND PULMONARY TUBERCULOSIS. ACTIVATION OF FOUR CASES.
    ESPERSEN E
    Acta Tuberc Pneumol Scand; 1963; 43():1-8. PubMed ID: 14051165
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical data on 4-4' diisoamyloxythiocarbanilide (Isoxyl).
    Hekking AM; De Voogd KK
    Antibiot Chemother; 1970; 16():128-35. PubMed ID: 4943579
    [No Abstract]   [Full Text] [Related]  

  • 31. [Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].
    Willa C; Favez G
    Acta Tuberc Pneumol Belg; 1969; 60(3):577-82. PubMed ID: 4906106
    [No Abstract]   [Full Text] [Related]  

  • 32. [Critical remarks on a clinical test of an antitubercular agent. Experiences with thiocarlide during collective work].
    Mlczoch F; Wildner F
    Prax Pneumol; 1969 Jan; 23(1):1-16. PubMed ID: 4978559
    [No Abstract]   [Full Text] [Related]  

  • 33. [CONTRIBUTION TO THE RADIOLOGICAL STUDY OF POSTPRIMARY SEGMENTAL PULMONARY TUBERCULOSIS AND ITS REGRESSIVE PROCESSES DURING CHEMOANTIBIOTIC THERAPY].
    AGATI G; DEROSA G
    Minerva Radiol Fisioter Radiobiol; 1963 Oct; 15():425-42. PubMed ID: 14108691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cooperative controlled trial of thiocarlide (DATC), PAS and bedrest alone in short-term single-drug treatment in retreated cavitary pulmonary tuberculosis].
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(2):115-39. PubMed ID: 4888206
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sensitivity testing of tubercle bacteria for diisoamyloxythiocarbanilide].
    Gubler HU; Friedrich T
    Schweiz Med Wochenschr; 1965 Dec; 95(49):1691-3. PubMed ID: 4959232
    [No Abstract]   [Full Text] [Related]  

  • 36. [ETHIONAMIDE-CYCLOSERINE COMBINATION IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE USUAL DRUGS].
    PEREZ JA; FARIAS CE
    Torax; 1963; 12():126-32. PubMed ID: 14158168
    [No Abstract]   [Full Text] [Related]  

  • 37. [New experiences with 4-4' diisomayloxythiocarbanilide (D.A.T.C.) in association with other antitubercular drugs in chronic pulmonary tuberculosis].
    Frati HI
    Rev Sanid Milit Argent; 1967; 66(1):71-4. PubMed ID: 5629062
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of 4,4'-diisoamyloxythiocarbanilide (Isoxyl) on tuberculosis in the mouse].
    KAKU R
    Kekkaku; 1963 Feb; 38():67-72. PubMed ID: 13965062
    [No Abstract]   [Full Text] [Related]  

  • 39. [EXPERIENCE WITH MORPHAZINAMIDE IN THE THERAPY OF PULMONARY TUBERCULOSIS].
    MONTANI LG
    G Ital Chemioter; 1963; 10():68-70. PubMed ID: 14079394
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations in the use of D-4' diisoamyloxythiocarbanilide (ISOXYL) in pulmonary tuberculosis.
    Punzalan JM; Rañoa CP; Nolasco B
    Newsette; 1970; 10(2):9-13. PubMed ID: 5203973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.